Randomized controlled study of chemoimmunotherapy with bestatin of acute nonlymphocytic leukemia in adults

This publication has 11 references indexed in Scilit:

• Randomized controlled study of chemoimmunotherapy of acute myelogenous leukemia (AML) in adults withNocardia Rubra cell-wall skeleton and irradiated allogeneic AML cells
  Cancer, 1986
• A randomized trial of chemoimmunotherapy of acute nonlymphocytic leukemia in adults using a protein-bound polysaccharide preparation
  Cancer Immunology, Immunotherapy, 1984
• The role of immunotherapy in acute myelogenous leukemia
  Archives of internal medicine (1960), 1983
• Morphological classification, response to therapy, and survival in 263 adult patients with acute nonlymphoblastic leukemia
  Blood, 1980
• Effect of bestatin on mouse immune system and experimental murine tumors.
  The Journal of Antibiotics, 1980
• Prognostic factors affecting remission, remission duration, and survival in adult acute nonlymphocytic leukemia
  Cancer, 1979
• RESTORATION OF IMPAIRED IMMUNE FUNCTIONS OF AGED ANIMALS BY CHRONIC BESTATIN TREATMENT
  1979
• Immunotherapy for acute myelogenous leukaemia: a controlled clinical study 2 1/2 years after entry of the last patient
  British Journal of Cancer, 1977
• Bestatin, an inhibitor of aminopeptidase B, produced by actinomycetes.
  The Journal of Antibiotics, 1976